FGF23 and chronic kidney disease: In CKD patients, the progressive reduction in renal function determines a phosphate retention that stimulates the synthesis of FGF23, which acts in the kidneys, reducing phosphate reabsorption and increasing phosphate excretion as well as calcium and sodium reabsorption [16].